Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Andreeff

Showing results (251-260 of 504) with videos related to

Pageof 51
Sort By:
Cancers|July 8, 2020
CXCR4 Inhibition Enhances Efficacy of FLT3 Inhibitors in FLT3-Mutated AML Augmented by Suppressed TGF-b SignalingBo-Reum Kim, Seung-Hyun Jung, A-Reum Han, et al.
Blood|November 3, 2010
Expression of ARC (apoptosis repressor with caspase recruitment domain), an antiapoptotic protein, is strongly prognostic in AMLBing Z Carter, Yi Hua Qiu, Nianxiang Zhang, et al.
Blood|March 6, 2014
Implications of the miR-10 family in chemotherapy response of NPM1-mutated AMLViolaine Havelange, Parvathi Ranganathan, Susan Geyer, et al.
Annals of Hematology|July 13, 2006
PML-RARalpha and AML1-ETO translocations are rarely associated with methylation of the RARbeta2 promoterYoko Tabe, Marina Konopleva, Yutaka Kondo, et al.
Molecular Cancer|November 20, 2009
Selective depletion of a minor subpopulation of B-chronic lymphocytic leukemia cells is followed by a delayed but progressive loss of bulk tumor cells and disease regressionAaron E Foster, Fatma V Okur, Ettore Biagi, et al.
Cancer|July 25, 2003
Results of decitabine (5-aza-2'deoxycytidine) therapy in 130 patients with chronic myelogenous leukemiaHagop M Kantarjian, Susan O'Brien, Jorge Cortes, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 5, 2006
Phase I/II study of the mammalian target of rapamycin inhibitor everolimus (RAD001) in patients with relapsed or refractory hematologic malignanciesKaren W L Yee, Zhihong Zeng, Marina Konopleva, et al.
Experimental Hematology & Oncology|October 17, 2018
Early detection of transformation to BPDCN in a patient with MDSKamal Chamoun, Sanam Loghavi, Naveen Pemmaraju, et al.
Blood|October 24, 2009
MicroRNA 29b functions in acute myeloid leukemiaRamiro Garzon, Catherine E A Heaphy, Violaine Havelange, et al.
The Journal of Biological Chemistry|August 25, 2005
2-Cyano-3,12-dioxooleana-1,9-dien-28-imidazolide (CDDO-Im) directly targets mitochondrial glutathione to induce apoptosis in pancreatic cancerIsmael Samudio, Marina Konopleva, Numsen Hail, et al.
Pageof 51

Showing results (251-260 of 504) with videos related to

Sort By:
Pageof 51
Cancers|July 8, 2020
CXCR4 Inhibition Enhances Efficacy of FLT3 Inhibitors in FLT3-Mutated AML Augmented by Suppressed TGF-b SignalingBo-Reum Kim, Seung-Hyun Jung, A-Reum Han, et al.
Blood|November 3, 2010
Expression of ARC (apoptosis repressor with caspase recruitment domain), an antiapoptotic protein, is strongly prognostic in AMLBing Z Carter, Yi Hua Qiu, Nianxiang Zhang, et al.
Blood|March 6, 2014
Implications of the miR-10 family in chemotherapy response of NPM1-mutated AMLViolaine Havelange, Parvathi Ranganathan, Susan Geyer, et al.
Annals of Hematology|July 13, 2006
PML-RARalpha and AML1-ETO translocations are rarely associated with methylation of the RARbeta2 promoterYoko Tabe, Marina Konopleva, Yutaka Kondo, et al.
Molecular Cancer|November 20, 2009
Selective depletion of a minor subpopulation of B-chronic lymphocytic leukemia cells is followed by a delayed but progressive loss of bulk tumor cells and disease regressionAaron E Foster, Fatma V Okur, Ettore Biagi, et al.
Cancer|July 25, 2003
Results of decitabine (5-aza-2'deoxycytidine) therapy in 130 patients with chronic myelogenous leukemiaHagop M Kantarjian, Susan O'Brien, Jorge Cortes, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 5, 2006
Phase I/II study of the mammalian target of rapamycin inhibitor everolimus (RAD001) in patients with relapsed or refractory hematologic malignanciesKaren W L Yee, Zhihong Zeng, Marina Konopleva, et al.
Experimental Hematology & Oncology|October 17, 2018
Early detection of transformation to BPDCN in a patient with MDSKamal Chamoun, Sanam Loghavi, Naveen Pemmaraju, et al.
Blood|October 24, 2009
MicroRNA 29b functions in acute myeloid leukemiaRamiro Garzon, Catherine E A Heaphy, Violaine Havelange, et al.
The Journal of Biological Chemistry|August 25, 2005
2-Cyano-3,12-dioxooleana-1,9-dien-28-imidazolide (CDDO-Im) directly targets mitochondrial glutathione to induce apoptosis in pancreatic cancerIsmael Samudio, Marina Konopleva, Numsen Hail, et al.
Pageof 51